Table 1. Unilateral cryptorchidism (n=103). Features based on testis location and therapy used (A-only hormonal treatment; B-hormonal first and surgery later; CX – surgery alone; TEST-Testosterone).
| Testis Location | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-Scrotal (36) | Inguinal (52) | Non Palpable (15) | |||||||
| Treatment | Hormonal therapy | CX | Hormonal therapy | CX | Hormonal Therapy | CX | |||
| Groups | A | B | A | B | A | B | |||
| Patients | 19 | 13 | 4 | 3 | 36 | 13 | 0 | 6 | 9 |
| FSH (UI/L) | 3.6 | 3.9 | 3.8 | 4.9 (*) | 3.7 | 4.4 | 4.03 | 3.8 | |
| Range | (1.7-7.6) | (3.3-8.8) | (2.5-6.0) | (2.6-5.9) | (2.3-9.2) | (3.4-4.6) | (2.3-8.4) | ||
| LH (UI/L) | 3.5 | 5.9 | 4.7 | 6.2 (*) | 3.8 | 3.3 | 3.93 | 3.25 | |
| Range | (3.1-5.5) | (2.6-7.5) | (3.4-5.8) | (2.8-5.1) | (2.8-5.4) | (3.1-4.6) | (2.7-4.3) | ||
| TEST. (Ng/mL) | 5.2 | 5.4 | 6.1 | 10.1 (*) | 6.3 | 5.6 | 10.0 | 5.3 | |
| Range | (4.8-9.1) | (4.1-6.8) | (5.3-9.8) | (5.2-8.1) | (4.5-6.6) | (4.6-18.2) | (3.9-11.9) | ||
| Age Treatment (months) | 84.6 | 98.7 | 140.7* | 121.2 (*) | 92.6 | 81.1 | 57.9 | 87.5 | |
| Range | (44.1-99.5) | (53.5-137.3) | (131-143) | (37.2-137) | (30.4-140.0) | (28.7-99.7) | (71.5-113.4) | ||
| Testicular Vol. | |||||||||
| Affected testis | 13.0 (10.0-17.8) | 11.3 (7.8-22.6) | 9.4 (8.8-10.2) | 10.7 (7.8-12.5) | 10.1**** (7.3-13.0) | 11.9** (8.05-14.4) | 6.3** (0.1-9.1) | 4.6 *** (0.1-10.5) | |
| Non affected testis | 13.5 (10.5-18.0) | 16.7 (13.1-22.1) | 9.8 (8.3-12.3) | 22.9 (11.0-24.3) | 14.8 (11.8-18.5) | 15.8 (11.9-21.3) | 16.4 (10.3-23.7) | 19.7 (16.0-30.6) | |
(*) Only 1 case with data
*p < 0.05; ** p <0.01; *** p < 0.005; **** P <0.001